We provide consultative services at most hospitals within the Cincinnati area. We also provide outpatient consultation at four offices that are conveniently located throughout the city.
To schedule a patient for an infectious disease consultation, call our central scheduling number: 513-624-0999
TriHealth Infectious Disease physicians provide primary and consultative care for patients with all stages of HIV infection. Our physicians have experience in all facets of HIV and AIDS disease management.
TriHealth Infectious Disease provides consulting for any healthcare or business entity that requires infection control services or assistance.
TriHealth Infectious Disease physicians can assist in disease outbreak investigation and participate in JCAHO or OSHA regulatory reviews on a contractual or as-needed basis.
We can also assist microbiology labs to develop cost-effective strategies for antimicrobial testing issues.
TriHealth Infectious Disease physicians are available to assist healthcare institutions or businesses in evaluating risks for exposure to infectious agents among their team member populations.
We can assist in defining policies and procedures for infectious disease exposure in the workplace.
TriHealth Infectious Disease provides consulting for any healthcare or business entity that requires infection control services or assistance.
TriHealth Infectious Disease physicians provide teaching opportunities for medical students, residents and allied health personnel through our affiliation with Greater Cincinnati hospitals.
TriHealth Infectious Disease physicians are available on a contractual basis to provide daily pharmacy rounds on patients receiving antimicrobial therapy.
Our physicians employ CDC recommended strategies for improving the appropriateness and cost effectiveness of antibiotic therapy within hospitals.
Our physicians direct and participate in clinical research programs through TriHealth medical residency programs.
Our physicians are widely published in a number of medical journals. TriHealth Infectious Disease plans to explore clinical pharmaceutical trials in the near future.